Thursday, January 19, 2023

7:00 AM-8:00 AM Complimentary Continental Breakfast
7:00 AM-5:45 PM Exhibits Open
7:50 AM-9:30 AM Controversies in Early-Stage Gastric and Esophageal Cancers

Welcome of the Day

20th Anniversary Opening Remarks

Expanded Indications of Endoscopic Therapy

Access to Care for Gastroesophageal Cancer

Patient-Reported Outcomes and Quality of Life After Esophagectomy

Moderated Panel Discussion

10:00 AM-11:00 AM Other Targets in Metastatic Esophageal and Gastric Cancers

Theranostics

Organoid Versus PDX for Advanced Disease

Other Targeted Therapy

Case Panel: Oligometastatic Disease

Moderated Panel Discussion

11:15 AM-12:00 PM Rapid Abstract Session A: Cancers of the Esophagus and Stomach
11:15 AM-12:00 PM Breakout Session: Managing Complications Across Treatment Modalities

Minimizing Complications Associated with Gastrectomy

Minimizing the Side Effects of Radiation

Minimizing Gastrointestinal Side Effects of Immunotherapy

Moderated Panel Discussion

12:00 PM-1:30 PM Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

With Complimentary Boxed Lunch

12:00 PM-1:30 PM Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

With Complimentary Boxed Lunch

12:15 PM-1:15 PM Trainee and Early-Career Networking Luncheon
1:30 PM-3:00 PM Oral Abstract Session A: Cancers of the Esophagus and Stomach
3:30 PM-4:45 PM Integration of Immunotherapy Across All Lines of Treatment

How Do We Incorporate Immunotherapy for MSI-H Localized GI Cancers?

Utilization of Immune Biomarkers and TMB in Clinical Practice

A Look at Novel Immune Therapies in GI Cancers: What’s Coming?

Moderated Panel Discussion

4:45 PM-5:45 PM Poster Session A (Continued) with Complimentary Wine and Cheese Reception
4:45 PM-5:45 PM Trials in Progress Poster Session A (Continued) with Complimentary Wine and Cheese Reception
5:00 PM-5:45 PM Poster Walks: Esophageal and Gastric Cancer and Other GI Cancers

Friday, January 20, 2023

6:30 AM-7:55 AM Complimentary Continental Breakfast
7:00 AM-5:30 PM Exhibits Open
7:00 AM-7:45 AM Rapid Abstract Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
7:00 AM-7:45 AM Breakout Session: Pushing the Envelope in Transplant Oncology

Debate: Liver Transplantation for Intrahepatic CCA and Metastatic Colorectal Cancer: Are We There Yet?–FOR

Debate: Liver Transplantation for Intrahepatic CCA and Metastatic Colorectal Cancer: Are We There Yet?–AGAINST

Rebuttals and Questions from Moderators

Moderated Panel Discussion

8:15 AM-9:30 AM Targeting the Tumor Microenvironment to Overcome Immune Resistance: Strategies and Future Directions

Welcome of the Day

Immunology for the Clinician: Understanding the Basics

Preclinical Mechanistic Strategies in Immuno-Oncology Modulation

Macrophage Targeting in GI Cancers

Panel Question and Answer

10:00 AM-11:00 AM Imaging and Therapy of NETS

Functional Imaging and PRRT: Practical Considerations and Future Directions

Updates on Systemic Therapies

Panel Discussion: Management of Local-Regional Therapies

Panel Question and Answer

11:15 AM-12:00 PM Keynote

AI in Oncology

Question and Answer

12:00 PM-1:30 PM Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

With Complimentary Boxed Lunch

12:00 PM-1:30 PM Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

With Complimentary Boxed Lunch

12:15 PM-1:15 PM Meet the Experts Networking Luncheon
1:30 PM-3:00 PM Oral Abstract Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
3:30 PM-4:30 PM Homologous Recombination Deficiency in Pancreaticobiliary Cancers

Beyond PARP Inhibitors

Genetic Risk in Biliary Tract Cancer

Immuno-Oncology Combinations

Moderated Panel Discussion

4:30 PM-5:30 PM Poster Session B (Continued) With Wine and Cheese Reception
4:30 PM-5:30 PM Trials in Progress Session B (Continued) With Wine and Cheese Reception
4:45 PM-5:30 PM Poster Walks: Hepatobiliary Cancer, Pancreatic Cancer, Small Bowel Cancer, and Neuroendocrine/Carcinoid
4:45 PM-5:30 PM Women’s Networking Reception

Saturday, January 21, 2023

6:30 AM-7:55 AM Poster Session C: Cancers of the Colon, Rectum, and Anus

With Complimentary Continental Breakfast

6:30 AM-7:55 AM Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

With Complimentary Continental Breakfast

7:00 AM-7:45 AM Rapid Abstract Session C: Cancers of the Colon, Rectum, and Anus
7:00 AM-7:45 AM Breakout Session: Germline Genetic Testing in Colorectal Cancer: Should It Be Performed Universally?

Introduction

Debate: Germline Genetic Testing Should be Performed Universally–FOR

Debate: Germline Genetic Testing Should be Performed Universally–AGAINST

Moderated Panel Discussion

8:10 AM-9:30 AM Circulating Tumor DNA: Prime Time or Jumping Too Soon?

Welcome of the Day

Adjuvant Therapy in Colon Cancer

Metastatic Pancreaticobiliary and Gastroesophageal Cancer

Moderated Panel Discussion

9:45 AM-10:30 AM Keynote

Equitable Solutions for Reducing Excess Mortality in Minority Populations

Question and Answer

11:00 AM-12:30 PM Oral Abstract Session C: Cancers of the Colon, Rectum, and Anus
12:30 PM-2:00 PM Poster Session C (Continued) With Complimentary Boxed Lunch
12:30 PM-2:00 PM Trials in Progress Poster Session C (Continued) With Complimentary Boxed Lunch
12:45 PM-1:30 PM Poster Walks: Anal Cancer and Colorectal Cancer
2:00 PM-3:00 PM State of the Art Non-operative Management of Rectal Cancer

Radiologic Biomarkers to Select Patients

A Surgical Viewpoint: When to Bring out the Scalpel

Intensifying or Substituting Chemotherapy to Maximize Eligible Patients: MMR Status Matters

Moderated Panel Discussion

3:15 PM-4:15 PM Refinement of Metastatic Colorectal Cancer Management

Debate: For a Fit Patient with Unresectable Metastatic RAS Wild-Type Sigmoid Colon Adenocarcinoma, First-Line EGFR Antibody Is an Essential Treatment–FOR

Debate: For a Fit Patient with Unresectable Metastatic RAS Wild-Type Sigmoid Colon Adenocarcinoma, First-Line EGFR Antibody Is an Essential Treatment–AGAINST

Intensifying Chemotherapy in mCRC: What, When, and How?

Tumor Board: Management of Recurrence after Hepatic Surgery

Moderated Panel Discussion

For more information: https://conferences.asco.org/gi/program